ATROPINE (AUTOINJECTOR)
Peakatropine injection, 2 mg
NDAINTRAMUSCULARSOLUTIONPriority Review
Approved
Jul 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
4/8 — Partial
Priority Review
ATROPINE (AUTOINJECTOR) (atropine injection, 2 mg) is cholinergic antagonists [moa]. Approved for poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity, carbamate insecticides in adults. First approved in 2018.
Drug data last refreshed 4d ago
Mechanism of Action
Cholinergic Antagonists
Pharmacologic Class:
Anticholinergic
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.